Defining aggressive disease in patients with advanced NSCLC receiving second-line treatment: A systematic review

K. Winfree; C. Ainsworth; A. Njue; C. Molife; M. Lyall; M. Jen; M. Bittoni; A. Heyes; D. Carbone

doi:doi:10.1016/j.jtho.2018.08.1671

Defining aggressive disease in patients with advanced NSCLC receiving second-line treatment

A systematic review

Winfree, K., Ainsworth, C., Njue, A., Molife, C., Lyall, M., Jen, M., Bittoni, M., Heyes, A., & Carbone, D. (2018). Defining aggressive disease in patients with advanced NSCLC receiving second-line treatment: A systematic review. Journal of Thoracic Oncology, 13(10), S908. https://doi.org/10.1016/j.jtho.2018.08.1671

Copy citation

Abstract

P3.01-110

Recent Publications

Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders

Defining aggressive disease in patients with advanced NSCLC receiving second-line treatment

Abstract

Publications Info

Recent Publications

Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders

Article

Grandi Byen-supporting child growth and development through integrated, responsive parenting, nutrition and hygiene

Article

Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions

Article

"Show Me the Energy Costs"